436 related articles for article (PubMed ID: 25171848)
1. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.
Teeter BS; Garza KB; Stevenson TL; Williamson MA; Zeek ML; Westrick SC
Vaccine; 2014 Sep; 32(43):5749-54. PubMed ID: 25171848
[TBL] [Abstract][Full Text] [Related]
2. Advocating zoster vaccination in a community pharmacy through use of personal selling.
Bryan AR; Liu Y; Kuehl PG
J Am Pharm Assoc (2003); 2013; 53(1):70-7. PubMed ID: 23636159
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Pharmacist Interventions on Herpes Zoster Vaccination Rates.
Eid DD; Meagher RC; Lengel AJ
Consult Pharm; 2015 Aug; 30(8):459-62. PubMed ID: 26260642
[TBL] [Abstract][Full Text] [Related]
4. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
Lu PJ; Euler GL; Jumaan AO; Harpaz R
Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
[TBL] [Abstract][Full Text] [Related]
5. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.
Yang TU; Cheong HJ; Song JY; Noh JY; Kim WJ
Hum Vaccin Immunother; 2015; 11(3):719-26. PubMed ID: 25785481
[TBL] [Abstract][Full Text] [Related]
6. Assessment of targeted automated messages on herpes zoster immunization numbers in an independent community pharmacy.
Bedwick BW; Garofoli GK; Elswick BM
J Am Pharm Assoc (2003); 2017; 57(3S):S293-S297.e1. PubMed ID: 28408168
[TBL] [Abstract][Full Text] [Related]
7. Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies.
Wang J; Ford LJ; Wingate L; Uroza SF; Jaber N; Smith CT; Randolph R; Lane S; Foster SL
J Am Pharm Assoc (2003); 2013; 53(1):46-53. PubMed ID: 23636155
[TBL] [Abstract][Full Text] [Related]
8. Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly.
Opstelten W; van Essen GA; Hak E
Vaccine; 2009 Jan; 27(2):192-6. PubMed ID: 18996427
[TBL] [Abstract][Full Text] [Related]
9. Determinants of shingles vaccine acceptance in the United Kingdom.
Bricout H; Torcel-Pagnon L; Lecomte C; Almas MF; Matthews I; Lu X; Wheelock A; Sevdalis N
PLoS One; 2019; 14(8):e0220230. PubMed ID: 31369608
[TBL] [Abstract][Full Text] [Related]
10. Herpes zoster vaccine awareness among people ≥ 50 years of age and its implications on immunization.
Javed S; Javed F; Mays RM; Tyring SK
Dermatol Online J; 2012 Aug; 18(8):2. PubMed ID: 22948052
[TBL] [Abstract][Full Text] [Related]
11. Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective.
Wood HM; McDonough RP; Doucette WR
J Am Pharm Assoc (2003); 2009; 49(1):12-7. PubMed ID: 19196591
[TBL] [Abstract][Full Text] [Related]
12. Studying physician knowledge, attitudes, and practices regarding the herpes zoster vaccine to address perceived barriers to vaccination.
Elkin Z; Cohen EJ; Goldberg JD; Gillespie C; Li X; Jung J; Cohen M; Park L; Perskin MH
Cornea; 2013 Jul; 32(7):976-81. PubMed ID: 23449488
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
[TBL] [Abstract][Full Text] [Related]
14. Improving pneumococcal and herpes zoster vaccination uptake: expanding pharmacist privileges.
Taitel MS; Fensterheim LE; Cannon AE; Cohen ES
Am J Manag Care; 2013 Sep; 19(9):e309-13. PubMed ID: 24449960
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany.
Bödeker B; Walter D; Reiter S; Wichmann O
Vaccine; 2014 Jul; 32(33):4131-9. PubMed ID: 24928791
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the herpes zoster vaccine Zostavax® in Stockholm County, Sweden.
Blom K; Yin L; Arnheim-Dahlström L
Vaccine; 2019 Jul; 37(31):4401-4406. PubMed ID: 31230884
[TBL] [Abstract][Full Text] [Related]
17. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease.
Tseng HF; Smith N; Harpaz R; Bialek SR; Sy LS; Jacobsen SJ
JAMA; 2011 Jan; 305(2):160-6. PubMed ID: 21224457
[TBL] [Abstract][Full Text] [Related]
18. [Shingles vaccine: which recommendations in 2014?].
Vionnet J; Hart K; Spertini F
Rev Med Suisse; 2014 Apr; 10(426):869-72, 874-5. PubMed ID: 24834646
[TBL] [Abstract][Full Text] [Related]
19. Herpes zoster knowledge, prevalence, and vaccination rate by race.
Joon Lee T; Hayes S; Cummings DM; Cao Q; Carpenter K; Heim L; Edwards H
J Am Board Fam Med; 2013; 26(1):45-51. PubMed ID: 23288280
[TBL] [Abstract][Full Text] [Related]
20. Why should older adults receive the shingles vaccine?
Harkness TL
J Gerontol Nurs; 2010 Oct; 36(10):51-5. PubMed ID: 20506935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
